Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Neoplasms, Plasma Cell 1Neoplasms 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Anemia 1

Interventions

Rituximab 49Cyclophosphamide 28venetoclax 24Bendamustine Hydrochloride 24obinutuzumab 22ibrutinib 21Chlorambucil 20fludarabine 16fludarabine phosphate 15idelalisib 13acalabrutinib 11pirtobrutinib 7ofatumumab 7zanubrutinib 5Vincristine 5Peripheral Blood Stem Cell Transplantation 5Mycophenolic Acid 5Cyclosporine 5Radiotherapy 4Prednisone 4Doxorubicin 4duvelisib 3Whole-Body Irradiation 3Specimen Handling 3Methotrexate 3Lenalidomide 3Filgrastim 3Epoetin Alfa 3Cyclosporins 3Biopsy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Lymphocytic, Chronic, B-Cell × Iron-Dextran Complex × Clear all
NCT00482716 2014-01-10

Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
80 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Anemia, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡